2015 Clinical Trials Consumption Terpenes 
The Cannigma
MAY 13, 2022
There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. The best type of cannabis for dealing with chronic pain tends to be type I or type II strain with a terpene profile that includes linalool, pinene, beta-caryophyllene, limonene, or myrcene. Can topical terpenes alone help with pain?
The Cannigma
MAY 17, 2022
We also don’t know which, if any, terpenes have an effect on creativity. The best strains for creativity are Type II, with a balance of THC and CBD and a terpene profile that includes pinene, linalool, and beta-caryophyllene. On the other hand, a 2015 study found that large doses of THC can actually make you less creative.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JUNE 20, 2021
A 2015 study performed on mice also found that running boosts blood levels of anandamide 3. Chocolate has been known to produce bliss regardless of cannabis consumption, so you may just be ingesting two things that feel good. The same terpenes are present in fresh herbs like basil as well as in cannabis. Beer and other alcohols.
Greencamp
AUGUST 16, 2018
Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.
Cannabis Law Report
NOVEMBER 24, 2021
Research into the plant’s chemical compounds has also revealed a rich array of terpenes and flavonoids that may also account for the plant’s therapeutic effects (Kotsirilos and McGregor 2021 ). 2015 ; Kaiser 2011 ; Mortensen et al. No negative articles appear in these medical publications until 2015. 29) and negative ( n ?=?26)
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Fig 1: Sucralose (In Study).
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Expert insights. Personalized for you.
111 
Let's personalize your content